Reports
As the novel coronavirus (COVID-19) continues to spread across the world, our analysts are constantly tracking the impact of this rapidly evolving situation on the markets and the consumer purchase behaviours. Thus, our latest estimates and analysis about the current market trends and forecast will exhaustively reflect the effects of this emerging pandemic.
Sale
Global Anaemia Drugs Market: By Anaemia Type: Iron Deficiency, CKD (Chronic Kidney Disease), Sickle Cell, Aplastic; By Drugs: Dietary Supplements, Medicines; By Distribution Channel: Hospital Pharmacy, Others; Regional Analysis; Historical Market and Forecast (2016-2026); Competitive Landscape; Industry Events and Developments
Global Anaemia Drugs Market Outlook
The global anaemia drugs market is expected to grow at a CAGR of 8% in the forecast period of 2021-2026.
Increase in Kidney Diseases to Aid the Market Growth of Anaemia Drugs
The market growth of anaemia drugs is being driven by the significant contribution by North America to the global market. This could be attributed to the increase in incidence of the condition, increase in kidney diseases, and unhealthy lifestyle across the region. In addition, rise in health care expenditure, high research activities, advanced technology, and increasing awareness about anaemia are predicted to bolster the anaemia drugs industry in the region. Europe is expected to follow North America, in terms of contribution to the overall market growth. The market in the Asia Pacific is predicted to grow rapidly over the forecast period as the result of rising healthcare expenditure, surge in disposable income, rise in geriatric population, increase in awareness, high prevalence of chronic diseases, and complications during pregnancy in many developing countries.
Anaemia Drugs: Industry Definition and Segmentation
Anaemia is a medical condition in which red blood cell (RBC) count or haemoglobin is less than normal. Anaemia results in shortness of breath, fatigue, palpitations, and dizziness. Anaemic drugs are used in the treatment of this condition.
On the basis of anaemia type, the market is divided into:
- Iron Deficiency
- CKD (Chronic Kidney Disease)
- Sickle Cell
- Aplastic
- Others
Based on drugs, the industry can be segmented into:
- Dietary Supplements
- Medicines
The dietary supplements are further divided on the basis of types into iron supplements and vitamin supplements, among others, whereas medicines are further divided into antibiotics, hormones (erythropoietin), chelation therapy (lead poisoning), among others.
By distribution channel, the industry is categorised into:
- Hospital Pharmacy
- Store Pharmacy
- Online
- Others
The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
Rising Prevalence of Anaemia to Aid the Market Growth of Anaemia Drugs
The market growth of anaemia drugs is being driven by the rising prevalence of this condition in children and women. In addition, factors such as unhealthy lifestyle, high number of women of reproductive age, development of pipeline products, and complications during pregnancy, especially in developing countries are expected to provide impetus over the forecast period. Further, rise in geriatric population, enhancing healthcare infrastructure, and rapid R&D are expected to fuel the market growth over the forecast period. However, factors like lack of awareness about health in many developing countries and expensive drugs are anticipated to hinder the market growth of anaemia drugs over the forecast period.
Key Industry Players in the Global Anaemia Drugs Market
The report gives a detailed analysis of the following key players in the global anaemia drugs market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:
- Amgen Inc.
- Pieris Pharmaceuticals, Inc.
- Pfizer Inc.
- Akebia Therapeutics, Inc.
- Takeda Pharmaceutical Company Limited
- Others
The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model along with giving a SWOT analysis.
1 Preface
2 Report Coverage – Key Segmentation and Scope
3 Report Description
3.1 Market Definition and Outlook
3.2 Properties and Applications
3.3 Market Analysis
3.4 Key Players
4 Key Assumptions
5 Executive Summary
5.1 Overview
5.2 Key Drivers
5.3 Key Developments
5.4 Competitive Structure
5.5 Key Industrial Trends
6 Snapshot
6.1 Global
6.2 Regional
7 Industry Opportunities and Challenges
8 Global Anaemia Drugs Market Analysis
8.1 Key Industry Highlights
8.2 Global Anaemia Drugs Historical Market (2016-2020)
8.3 Global Anaemia Drugs Market Forecast (2021-2026)
8.4 Global Anaemia Drugs Market by Anaemia Type
8.4.1 Iron Deficiency
8.4.1.1 Market Share
8.4.1.2 Historical Trend (2016-2020)
8.4.1.3 Forecast Trend (2021-2026)
8.4.2 CKD (Chronic Kidney Disease)
8.4.2.1 Market Share
8.4.2.2 Historical Trend (2016-2020)
8.4.2.3 Forecast Trend (2021-2026)
8.4.3 Sickle Cell
8.4.3.1 Market Share
8.4.3.2 Historical Trend (2016-2020)
8.4.3.3 Forecast Trend (2021-2026)
8.4.4 Aplastic
8.4.4.1 Market Share
8.4.4.2 Historical Trend (2016-2020)
8.4.4.3 Forecast Trend (2021-2026)
8.4.5 Others
8.5 Global Anaemia Drugs Market by Drugs
8.5.1 Dietary Supplements
8.5.1.1 Market Share
8.5.1.2 Historical Trend (2016-2020)
8.5.1.3 Forecast Trend (2021-2026)
8.5.1.4 Breakup by Type
8.5.1.4.1 Iron supplements
8.5.1.4.1.1 Market Share
8.5.1.4.1.2 Historical Trend (2016-2020)
8.5.1.4.1.3 Forecast Trend (2021-2026)
8.5.1.4.2 Vitamin supplements
8.5.1.4.2.1 Market Share
8.5.1.4.2.2 Historical Trend (2016-2020)
8.5.1.4.2.3 Forecast Trend (2021-2026)
8.5.1.4.3 Others
8.5.2 Medicines
8.5.2.1 Market Share
8.5.2.2 Historical Trend (2016-2020)
8.5.2.3 Forecast Trend (2021-2026)
8.5.2.4 Breakup by Type
8.5.2.4.1 Antibiotics
8.5.2.4.1.1 Market Share
8.5.2.4.1.2 Historical Trend (2016-2020)
8.5.2.4.1.3 Forecast Trend (2021-2026)
8.5.2.4.2 Hormones (Erythropoietin)
8.5.2.4.2.1 Market Share
8.5.2.4.2.2 Historical Trend (2016-2020)
8.5.2.4.2.3 Forecast Trend (2021-2026)
8.5.2.4.3 Chelation Therapy (Lead Poisoning)
8.5.2.4.3.1 Market Share
8.5.2.4.3.2 Historical Trend (2016-2020)
8.5.2.4.3.3 Forecast Trend (2021-2026)
8.5.2.4.4 Others
8.6 Global Anaemia Drugs Market by Distribution Channel
8.6.1 Hospital Pharmacy
8.6.1.1 Market Share
8.6.1.2 Historical Trend (2016-2020)
8.6.1.3 Forecast Trend (2021-2026)
8.6.2 Store Pharmacy
8.6.2.1 Market Share
8.6.2.2 Historical Trend (2016-2020)
8.6.2.3 Forecast Trend (2021-2026)
8.6.3 Online
8.6.3.1 Market Share
8.6.3.2 Historical Trend (2016-2020)
8.6.3.3 Forecast Trend (2021-2026)
8.6.4 Others
8.7 Global Anaemia Drugs Market by Region
8.7.1 Market Share
8.7.1.1 North America
8.7.1.2 Europe
8.7.1.3 Asia Pacific
8.7.1.4 Latin America
8.7.1.5 Middle East and Africa
9 Regional Analysis
9.1 North America
9.1.1 Historical Trend (2016-2020)
9.1.2 Forecast Trend (2021-2026)
9.1.3 Breakup by Country
9.1.3.1 United States of America
9.1.3.2 Canada
9.2 Europe
9.2.1 Historical Trend (2016-2020)
9.2.2 Forecast Trend (2021-2026)
9.2.3 Breakup by Country
9.2.3.1 United Kingdom
9.2.3.2 Germany
9.2.3.3 France
9.2.3.4 Italy
9.2.3.5 Others
9.3 Asia Pacific
9.3.1 Historical Trend (2016-2020)
9.3.2 Forecast Trend (2021-2026)
9.3.3 Breakup by Country
9.3.3.1 China
9.3.3.2 Japan
9.3.3.3 India
9.3.3.4 ASEAN
9.3.3.5 Australia
9.3.3.6 Others
9.4 Latin America
9.4.1 Historical Trend (2016-2020)
9.4.2 Forecast Trend (2021-2026)
9.4.3 Breakup by Country
9.4.3.1 Brazil
9.4.3.2 Argentina
9.4.3.3 Mexico
9.4.3.4 Others
9.5 Middle East and Africa
9.5.1 Historical Trend (2016-2020)
9.5.2 Forecast Trend (2021-2026)
9.5.3 Breakup by Country
9.5.3.1 Saudi Arabia
9.5.3.2 United Arab Emirates
9.5.3.3 Nigeria
9.5.3.4 South Africa
9.5.3.5 Others
10 Market Dynamics
10.1 SWOT Analysis
10.1.1 Strengths
10.1.2 Weaknesses
10.1.3 Opportunities
10.1.4 Threats
10.2 Porter’s Five Forces Analysis
10.2.1 Supplier’s Power
10.2.2 Buyer’s Power
10.2.3 Threat of New Entrants
10.2.4 Degree of Rivalry
10.2.5 Threat of Substitutes
10.3 EMR’s Key Indicators for Demand
10.4 EMR’s Key Indicators for Price
11 Value Chain Analysis
12 Competitive Landscape
12.1 Market Structure
12.2 Company Profiles
12.2.1 Amgen Inc.
12.2.1.1 Company Overview
12.2.1.2 Product Portfolio
12.2.1.3 Demographic Reach and Achievements
12.2.1.4 Certifications
12.2.2 Pieris Pharmaceuticals, Inc.
12.2.2.1 Company Overview
12.2.2.2 Product Portfolio
12.2.2.3 Demographic Reach and Achievements
12.2.2.4 Certifications
12.2.3 Pfizer Inc.
12.2.3.1 Company Overview
12.2.3.2 Product Portfolio
12.2.3.3 Demographic Reach and Achievements
12.2.3.4 Certifications
12.2.4 Akebia Therapeutics, Inc.
12.2.4.1 Company Overview
12.2.4.2 Product Portfolio
12.2.4.3 Demographic Reach and Achievements
12.2.4.4 Certifications
12.2.5 Takeda Pharmaceutical Company Limited
12.2.5.1 Company Overview
12.2.5.2 Product Portfolio
12.2.5.3 Demographic Reach and Achievements
12.2.5.4 Certifications
12.2.6 Others
13 Industry Events and Developments
List of Figures and Tables
1. Global Anaemia Drugs Market: Key Industry Highlights, 2015 and 2025
2. Global Anaemia Drugs Historical Market: Breakup by Anaemia Type (USD Billion), 2016-2020
3. Global Anaemia Drugs Market Forecast: Breakup by Anaemia Type (USD Billion), 2021-2026
4. Global Anaemia Drugs Historical Market: Breakup by Drugs (USD Billion), 2016-2020
5. Global Anaemia Drugs Market Forecast: Breakup by Drugs (USD Billion), 2021-2026
6. Global Anaemia Drugs Historical Market: Breakup by Distribution Channel (USD Billion), 2016-2020
7. Global Anaemia Drugs Market Forecast: Breakup by Distribution Channel (USD Billion), 2021-2026
8. Global Anaemia Drugs Historical Market: Breakup by Region (USD Billion), 2016-2020
9. Global Anaemia Drugs Market Forecast: Breakup by Region (USD Billion), 2021-2026
10. North America Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
11. North America Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
12. Europe Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
13. Europe Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
14. Asia Pacific Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
15. Asia Pacific Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
16. Latin America Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
17. Latin America Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
18. Middle East and Africa Anaemia Drugs Historical Market: Breakup by Country (USD Billion), 2016-2020
19. Middle East and Africa Anaemia Drugs Market Forecast: Breakup by Country (USD Billion), 2021-2026
20. Global Anaemia Drugs Market Structure
Key Questions Answered in the Report
The global anaemia drugs market is projected to grow at a CAGR of 8% between 2021 and 2026.
The major drivers of the industry such as rising prevalence of this condition, development of pipeline products, increasing geriatric population, and rising demand from the developing regions are expected to aid the market growth.
The key market trend guiding the growth of the industry include the enhancing healthcare infrastructure and rapid R&D.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
The leading anaemia types considered in the market report are iron deficiency, CKD (chronic kidney disease), sickle cell, and aplastic, among others.
The major drugs in the industry are dietary supplements and medicines.
The significant distribution channels in the market are hospital pharmacy, store pharmacy, and online, among others.
The major players in the industry are Amgen Inc., Pieris Pharmaceuticals, Inc., Pfizer Inc., Akebia Therapeutics, Inc., and Takeda Pharmaceutical Company Limited, among others.
Analyst Review
The global anaemia drugs market is being driven by the rising geriatric population. Aided by the growing R&D activities, the market is expected to witness a healthy growth in the forecast period of 2021-2026, growing at a CAGR of 8%.
EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. By anaemia type, the market is segmented into iron deficiency, CKD (chronic kidney disease), sickle cell, and aplastic, among others. On the basis of drugs, the industry is bifurcated into dietary supplements and medicines. Based on distribution channel, the market is divided into hospital pharmacy, store pharmacy, and online, among others. The major regional markets for anaemia drugs are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market include Amgen Inc., Pieris Pharmaceuticals, Inc., Pfizer Inc., Akebia Therapeutics, Inc., and Takeda Pharmaceutical Company Limited, among others.
EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.
Purchase Options
Call us on
Purchase Full Report
Mini Report
$ 1999
$1499
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateSingle User License
$3199$2499-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next UpdateFive User License
$4199$3499-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$5199$4499-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Contact AnalystAny Question? Speak With An Analyst
Request SampleView A Sample
Request CustomisationDid You Miss Anything, Ask Now
Why Expert Market Research?RIGHT PEOPLE
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
RIGHT METHODOLOGY
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
RIGHT PRICE
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
RIGHT SUPPORT
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
Similar ReportsRadiodermatitis Market Size, Share, Analysis, Growth, Report 2021-2026
Parkinson’s Disease Drugs Market Size, Share, Growth, Report 2021-2026
Veterinary Drugs Market Size, Share, Report and Forecast 2021-2026
Cardiovascular Drugs Market Size, Share, Price, Trends, Report 2021-2026
Prothrombin Complex Concentrate (PCC) Market Size, Share, Report 2021-2026
NEWSLETTER